title: Efficacy of a commercial mycotoxin binder in alleviating effects of ochratoxin A, fumonisin B1, moniliformin and zearalenone in adult mink.
abstract: The addition of nutritionally inert adsorbents to mycotoxin-contaminated animal feed has been a popular approach to decreasing toxicity in animals and carryover of mycotoxins from contaminated feed to animal by-products. Some studies suggest that esterified glucomannan derived from the cell wall of Saccharomyces cerevisiae is effective in reducing the bioavailability of at least some of the mycotoxins occurring in contaminated feed. Because cereal grains are important components of ranch mink diets, mycotoxicoses in mink is a potential problem faced by mink ranchers. We conducted a series of studies to determine if inclusion of a commercially available esterified glucomannan in ranch mink feed was effective in alleviating clinical signs indicative of exposure to ochratoxin A, fumonisin B1, moniliformin or zearalenone in adult mink. In 4 separate trials, mink were fed diets that contained 2.5, 5 or 10 mg ochratoxin A/kg feed, 200 mg fumonisin B1/kg feed, 20 mg moniliformin/kg feed, or 30 mg zearalenone/kg feed with or without 2 g esterified glucomannan/kg feed. Male mink fed diets containing ochratoxin A had significantly decreased feed intake as well as renal lesions characteristic of exposure to that mycotoxin. Inclusion of the esterified glucomannan did not ameliorate these effects. Male mink exposed to fumonisin B1 had increased urinary sphinganine concentration, which was not significantly reduced by the mycotoxin adsorbent. Male mink that consumed monilformin-contaminated diets had characteristic ultrastructural changes in the heart that were not reduced in severity by the esterified glucomannan. Female mink exposed to zearalenone had increased uterine weight, which was not reversed by inclusion of commercial mycotoxin binder in the contaminated feed. The results of this study suggest that a commercial esterified glucomannan was generally ineffective in alleviating effects indicative of exposure to ochratoxin A, fumonisin B1, monilformin and zearalenone in mink.
authors.affiliation: Department of Animal Science, Michigan State University, East Lansing, MI 48824, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Bursian
authors.forename: R R
authors.initials: RR
authors.lastname: Mitchell
authors.forename: B
authors.initials: B
authors.lastname: Yamini
authors.forename: S D
authors.initials: SD
authors.lastname: Fitzgerald
authors.forename: P A
authors.initials: PA
authors.lastname: Murphy
authors.forename: G
authors.initials: G
authors.lastname: Fernandez
authors.forename: G E
authors.initials: GE
authors.lastname: Rottinghaus
authors.forename: L
authors.initials: L
authors.lastname: Moran
authors.forename: K
authors.initials: K
authors.lastname: Leefers
authors.forename: I
authors.initials: I
authors.lastname: Choi
authors.forename: G
authors.initials: G
authors.lastname: Fernadez
mesh_terms: D000327:Adsorption; D000821:Animal Feed; D000818:Animals; D003503:Cyclobutanes / Q000633:toxicity; D005260:Female; D005506:Food Contamination / Q000517:prevention & control*; D037341:Fumonisins / Q000633:toxicity; D008297:Male; D008351:Mannans / Q000494:pharmacology*; D008907:Mink; D015651:Mycotoxicosis / Q000517:prevention & control / Q000662:veterinary*; D009183:Mycotoxins / Q000633:toxicity*; D009793:Ochratoxins / Q000633:toxicity; D015025:Zearalenone / Q000633:toxicity
chemical_list: D003503:Cyclobutanes; D037341:Fumonisins; D008351:Mannans; D009183:Mycotoxins; D009793:Ochratoxins; C025589:ochratoxin A; C008539:moniliformin; C022901:(1-6)-alpha-glucomannan; C056933:fumonisin B1; D015025:Zearalenone